Free Trial

Haleon (HLN) Competitors

GBX 389.70
+1.60 (+0.41%)
(As of 09/6/2024 ET)

HLN vs. ULVR, SN, SGE, WHR, CLX, ANP, TPX, PNPL, LEG, and HIK

Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Unilever (ULVR), Smith & Nephew (SN), The Sage Group (SGE), Warehouse REIT (WHR), Calnex Solutions (CLX), Anpario (ANP), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), and Hikma Pharmaceuticals (HIK).

Haleon vs.

Haleon (LON:HLN) and Unilever (LON:ULVR) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, community ranking, media sentiment, profitability, valuation and dividends.

Unilever received 1003 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 58.18% of users gave Unilever an outperform vote while only 29.73% of users gave Haleon an outperform vote.

CompanyUnderperformOutperform
HaleonOutperform Votes
11
29.73%
Underperform Votes
26
70.27%
UnileverOutperform Votes
1014
58.18%
Underperform Votes
729
41.82%

39.1% of Haleon shares are owned by institutional investors. Comparatively, 52.7% of Unilever shares are owned by institutional investors. 18.3% of Haleon shares are owned by company insiders. Comparatively, 0.1% of Unilever shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Unilever has a net margin of 11.01% compared to Haleon's net margin of 9.66%. Unilever's return on equity of 32.37% beat Haleon's return on equity.

Company Net Margins Return on Equity Return on Assets
Haleon9.66% 6.82% 4.45%
Unilever 11.01%32.37%8.62%

Haleon has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Comparatively, Unilever has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500.

Haleon presently has a consensus target price of GBX 367.50, indicating a potential downside of 5.70%. Unilever has a consensus target price of GBX 4,665, indicating a potential downside of 6.42%. Given Haleon's higher possible upside, research analysts plainly believe Haleon is more favorable than Unilever.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haleon
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Unilever
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Unilever had 5 more articles in the media than Haleon. MarketBeat recorded 6 mentions for Unilever and 1 mentions for Haleon. Unilever's average media sentiment score of 0.30 beat Haleon's score of 0.10 indicating that Unilever is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haleon
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Unilever
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.5%. Unilever pays an annual dividend of GBX 147 per share and has a dividend yield of 2.9%. Haleon pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Unilever pays out 6,621.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Unilever has higher revenue and earnings than Haleon. Unilever is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haleon£11.26B3.15£1.09B£0.123,247.50
Unilever£60.29B2.06£6.64B£2.222,245.50

Summary

Unilever beats Haleon on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLN vs. The Competition

MetricHaleonDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£35.50B£1.23B£5.66B£1.50B
Dividend Yield1.64%3.19%2.72%10.83%
P/E Ratio3,247.50202.46132.001,787.93
Price / Sales3.155,832.571,747.36370,501.16
Price / Cash21.9510.2738.6335.43
Price / Book2.143.104.952.70
Net Income£1.09B£169.43M£114.59M£154.94M
7 Day Performance2.02%0.87%-1.52%-1.48%
1 Month Performance4.20%2.35%8.44%0.23%
1 Year Performance23.62%94.41%12.43%92.31%

Haleon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ULVR
Unilever
0.2596 of 5 stars
0.26 / 5 stars
GBX 4,945.01
-0.3%
GBX 4,665
-5.7%
+25.2%£123.13B£60.29B2,207.59148,000High Trading Volume
SN
Smith & Nephew
3.1017 of 5 stars
3.10 / 5 stars
GBX 1,174
+0.9%
GBX 3,956.20
+237.0%
+14.0%£10.24B£5.64B4,348.1518,452High Trading Volume
SGE
The Sage Group
0.7447 of 5 stars
0.74 / 5 stars
GBX 994.20
-1.9%
GBX 1,173
+18.0%
-0.5%£9.93B£2.25B3,823.8511,326Dividend Increase
News Coverage
WHR
Warehouse REIT
1.0575 of 5 stars
1.06 / 5 stars
GBX 86.19
-0.1%
GBX 108
+25.3%
+4.2%£366.19M£50.10M-319.2361,000News Coverage
CLX
Calnex Solutions
1.1292 of 5 stars
1.13 / 5 stars
GBX 55.08
-0.6%
GBX 115
+108.8%
-56.2%£48.22M£16.27M1,756.339,000
ANP
Anpario
0 of 5 stars
0.00 / 5 stars
GBX 265
-0.9%
GBX 340
+28.3%
+25.1%£44.81M£31M2,038.465,500News Coverage
TPX
TPXimpact
0 of 5 stars
0.00 / 5 stars
GBX 43
-2.3%
N/A+8.0%£39.26M£84.27M-179.1712,000Gap Down
PNPL
Pineapple Power
0 of 5 stars
0.00 / 5 stars
GBX 2.74
-5.5%
N/A+0.0%£2.28MN/A-274.002High Trading Volume
LEG
Legendary Investments
0 of 5 stars
0.00 / 5 stars
GBX 0.09
-5.6%
N/A+0.0%£0.00N/A0.0019,900Gap Down
HIK
Hikma Pharmaceuticals
1.3398 of 5 stars
1.34 / 5 stars
GBX 1,943
-0.9%
GBX 2,325
+19.7%
-6.6%£4.31B£3.02B2,989.239,100High Trading Volume

Related Companies and Tools

This page (LON:HLN) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners